SI-BONE, Inc. (NASDAQ:SIBN) Given Consensus Rating of Buy by Brokerages

SI-BONE, Inc. (NASDAQ:SIBN – Free Report) has received a consensus rating of “Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $26.25. A […]

Related Keywords

United States ,America ,Anthonyj Recupero ,Jeryll Hilleman , ,Larson Financial Group ,Ensign Peak Advisors Inc ,Tower Research Capital ,Needham Company ,Nasdaq ,Securities Exchange Commission ,Free Report ,Exchange Commission ,Director Jeryl ,Financial Group ,Peak Advisors Inc ,Research Capital ,Si Bone ,Nasdaq Sibn ,Sibn ,Medical ,Ratings ,Consensus ,